Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Lung Neoplasms 8 Hematologic Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Hodgkin Disease 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Motor Activity 3 Pancreatic Neoplasms 2 Obesity 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Hematopoietic and Lymphoid System Neoplasm 2 Gastrointestinal Diseases 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Trastuzumab Cardiotoxicity 1 Small Cell Lung Carcinoma 1 Sedentary Behavior 1 Sarcopenia 1 Polycystic Ovary Syndrome 1 Pelvic Neoplasms 1 Pathologically Proven Gastrointestinal Malignancy 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Myocardial Fibrosis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1

Interventions

pembrolizumab 12 Radiotherapy 9 avelumab 8 Nivolumab 8 cemiplimab 4 Radiation 4 Ipilimumab 4 poly ICLC 3 atezolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Cyclophosphamide 3 talimogene laherparepvec 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 Carboplatin 2 Biopsy 2 veliparib 1 vatalanib 1 tremelimumab 1 tocilizumab 1 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Merkel Cell × Exercise Test × Clear all

NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡